Drugmakers were in the spotlight Wednesday as GSK recalls Zantac after U.S. regulators found probable cancer-causing impurities in the drug. Also in the U.S.: a jury says Johnson & Johnson must pay $8 billion in a case over male breast growth linked to Risperdal. David Pollard reports.
Peoples are using these keywords: Zantac, Zantac gsk, recall, Johnsonjohnson, Withdrawal, Glaxo, Ranitidine, Risperdal, gsk, Jj

You might also like this

LEAVE A REPLY

Please enter your comment!
Please enter your name here